US Stock MarketDetailed Quotes

Lixte Biotechnology (LIXT)

Watchlist
  • 3.350
  • +0.190+6.01%
Close Jan 22 16:00 ET
29.16MMarket Cap-2.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lixte Biotechnology (LIXT) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
226.22%5.34M
-65.81%887.21K
-59.44%1.38M
-75.28%1.04M
-75.28%1.04M
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-Cash and cash equivalents
76.35%2.89M
-65.81%887.21K
-59.44%1.38M
-75.28%1.04M
-75.28%1.04M
-67.92%1.64M
-10.91%2.6M
-16.49%3.41M
-21.48%4.2M
-21.48%4.2M
-Short-term investments
--2.45M
----
----
----
----
----
----
----
----
----
Prepaid assets
77.90%91.33K
41.67%102.54K
-25.96%129.53K
1.35%106.55K
1.35%106.55K
-49.29%51.34K
-45.44%72.38K
-6.15%174.94K
-49.36%105.13K
-49.36%105.13K
Total current assets
221.72%5.43M
-62.90%989.75K
-57.81%1.51M
-73.41%1.15M
-73.41%1.15M
-67.74%1.69M
-13.81%2.67M
-17.12%3.59M
-22.52%4.31M
-22.52%4.31M
Non current assets
Non current deferred assets
----
--198.83K
----
----
----
--6.93K
----
----
----
----
Total non current assets
--0
--198.83K
--0
--0
--0
--6.93K
--0
--0
--0
--0
Total assets
220.40%5.43M
-55.44%1.19M
-57.81%1.51M
-73.41%1.15M
-73.41%1.15M
-67.60%1.7M
-13.81%2.67M
-17.12%3.59M
-22.52%4.31M
-22.52%4.31M
Liabilities
Current liabilities
Payables
--286.27K
--92.15K
----
----
----
----
----
----
----
----
-accounts payable
--235.9K
--92.15K
----
----
----
----
----
----
----
----
-Dividends payable
--50.37K
----
----
----
----
----
----
----
----
----
Current accrued expenses
----
--188.83K
----
----
----
----
----
----
----
----
Current deferred liabilities
-8.18%235.16K
-11.69%256.15K
12.25%242.62K
49.64%235.08K
49.64%235.08K
182.78%256.1K
703.80%290.06K
720.11%216.15K
-4.80%157.1K
-4.80%157.1K
Current liabilities
58.51%521.42K
27.44%537.12K
-23.28%355.1K
1.41%318.28K
1.41%318.28K
5.52%328.96K
4.68%421.47K
85.14%462.84K
-20.69%313.86K
-20.69%313.86K
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
58.51%521.42K
27.44%537.12K
-23.28%355.1K
1.41%318.28K
1.41%318.28K
5.52%328.96K
4.68%421.47K
85.14%462.84K
-20.69%313.86K
-20.69%313.86K
Shareholders'equity
Share capital
-27.04%2.55M
-99.99%276
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
-0.04%3.5M
0.00%3.5M
0.00%3.5M
-common stock
153.33%570
22.67%276
19.11%268
0.00%225
0.00%225
0.00%225
35.54%225
-86.49%225
35.54%225
35.54%225
-Preferred stock
-27.05%2.55M
--0
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
0.00%3.5M
Retained earnings
-7.94%-55.53M
-6.12%-53.55M
-6.72%-52.78M
-7.40%-52.07M
-7.40%-52.07M
-8.43%-51.45M
-8.69%-50.46M
-10.48%-49.45M
-11.72%-48.48M
-11.72%-48.48M
Paid-in capital
17.39%57.89M
10.15%54.2M
2.76%50.44M
0.85%49.39M
0.85%49.39M
0.91%49.32M
7.86%49.21M
8.24%49.08M
8.69%48.98M
8.69%48.98M
Total stockholders'equity
259.36%4.91M
-71.00%651.46K
-62.92%1.16M
-79.29%827.22K
-79.29%827.22K
-72.23%1.37M
-16.58%2.25M
-23.39%3.13M
-22.66%3.99M
-22.66%3.99M
Total equity
259.36%4.91M
-71.00%651.46K
-62.92%1.16M
-79.29%827.22K
-79.29%827.22K
-72.23%1.37M
-16.58%2.25M
-23.39%3.13M
-22.66%3.99M
-22.66%3.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 226.22%5.34M-65.81%887.21K-59.44%1.38M-75.28%1.04M-75.28%1.04M-67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M
-Cash and cash equivalents 76.35%2.89M-65.81%887.21K-59.44%1.38M-75.28%1.04M-75.28%1.04M-67.92%1.64M-10.91%2.6M-16.49%3.41M-21.48%4.2M-21.48%4.2M
-Short-term investments --2.45M------------------------------------
Prepaid assets 77.90%91.33K41.67%102.54K-25.96%129.53K1.35%106.55K1.35%106.55K-49.29%51.34K-45.44%72.38K-6.15%174.94K-49.36%105.13K-49.36%105.13K
Total current assets 221.72%5.43M-62.90%989.75K-57.81%1.51M-73.41%1.15M-73.41%1.15M-67.74%1.69M-13.81%2.67M-17.12%3.59M-22.52%4.31M-22.52%4.31M
Non current assets
Non current deferred assets ------198.83K--------------6.93K----------------
Total non current assets --0--198.83K--0--0--0--6.93K--0--0--0--0
Total assets 220.40%5.43M-55.44%1.19M-57.81%1.51M-73.41%1.15M-73.41%1.15M-67.60%1.7M-13.81%2.67M-17.12%3.59M-22.52%4.31M-22.52%4.31M
Liabilities
Current liabilities
Payables --286.27K--92.15K--------------------------------
-accounts payable --235.9K--92.15K--------------------------------
-Dividends payable --50.37K------------------------------------
Current accrued expenses ------188.83K--------------------------------
Current deferred liabilities -8.18%235.16K-11.69%256.15K12.25%242.62K49.64%235.08K49.64%235.08K182.78%256.1K703.80%290.06K720.11%216.15K-4.80%157.1K-4.80%157.1K
Current liabilities 58.51%521.42K27.44%537.12K-23.28%355.1K1.41%318.28K1.41%318.28K5.52%328.96K4.68%421.47K85.14%462.84K-20.69%313.86K-20.69%313.86K
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 58.51%521.42K27.44%537.12K-23.28%355.1K1.41%318.28K1.41%318.28K5.52%328.96K4.68%421.47K85.14%462.84K-20.69%313.86K-20.69%313.86K
Shareholders'equity
Share capital -27.04%2.55M-99.99%2760.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M-0.04%3.5M0.00%3.5M0.00%3.5M
-common stock 153.33%57022.67%27619.11%2680.00%2250.00%2250.00%22535.54%225-86.49%22535.54%22535.54%225
-Preferred stock -27.05%2.55M--00.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M0.00%3.5M
Retained earnings -7.94%-55.53M-6.12%-53.55M-6.72%-52.78M-7.40%-52.07M-7.40%-52.07M-8.43%-51.45M-8.69%-50.46M-10.48%-49.45M-11.72%-48.48M-11.72%-48.48M
Paid-in capital 17.39%57.89M10.15%54.2M2.76%50.44M0.85%49.39M0.85%49.39M0.91%49.32M7.86%49.21M8.24%49.08M8.69%48.98M8.69%48.98M
Total stockholders'equity 259.36%4.91M-71.00%651.46K-62.92%1.16M-79.29%827.22K-79.29%827.22K-72.23%1.37M-16.58%2.25M-23.39%3.13M-22.66%3.99M-22.66%3.99M
Total equity 259.36%4.91M-71.00%651.46K-62.92%1.16M-79.29%827.22K-79.29%827.22K-72.23%1.37M-16.58%2.25M-23.39%3.13M-22.66%3.99M-22.66%3.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -